Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2001 Dec;10(6):288–291. doi: 10.1080/09629350152700902

Decreased prevalence of asthma among children with high exposure to cat allergen: relevance of the modified Th2 response.

T A Platts-Mills 1, J W Vaughan 1, K Blumenthal 1, J A Woodfolk 1, R B Sporik 1
PMCID: PMC1781735  PMID: 11817662

Full Text

The Full Text of this article is available as a PDF (113.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akdis C. A., Blesken T., Akdis M., Wüthrich B., Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest. 1998 Jul 1;102(1):98–106. doi: 10.1172/JCI2250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnes P. J. Anti-IgE antibody therapy for asthma. N Engl J Med. 1999 Dec 23;341(26):2006–2008. doi: 10.1056/NEJM199912233412610. [DOI] [PubMed] [Google Scholar]
  3. Benjaponpitak S., Oro A., Maguire P., Marinkovich V., DeKruyff R. H., Umetsu D. T. The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy. J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):468–475. doi: 10.1016/s0091-6749(99)70473-2. [DOI] [PubMed] [Google Scholar]
  4. Boguniewicz M., Martin R. J., Martin D., Gibson U., Celniker A., Williams M., Leung D. Y. The effects of nebulized recombinant interferon-gamma in asthmatic airways. J Allergy Clin Immunol. 1995 Jan;95(1 Pt 1):133–135. doi: 10.1016/s0091-6749(95)70162-1. [DOI] [PubMed] [Google Scholar]
  5. Borish L. C., Nelson H. S., Lanz M. J., Claussen L., Whitmore J. B., Agosti J. M., Garrison L. Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med. 1999 Dec;160(6):1816–1823. doi: 10.1164/ajrccm.160.6.9808146. [DOI] [PubMed] [Google Scholar]
  6. Borish L., Aarons A., Rumbyrt J., Cvietusa P., Negri J., Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol. 1996 Jun;97(6):1288–1296. doi: 10.1016/s0091-6749(96)70197-5. [DOI] [PubMed] [Google Scholar]
  7. Bryan S. A., O'Connor B. J., Matti S., Leckie M. J., Kanabar V., Khan J., Warrington S. J., Renzetti L., Rames A., Bock J. A. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2000 Dec 23;356(9248):2149–2153. doi: 10.1016/S0140-6736(00)03497-8. [DOI] [PubMed] [Google Scholar]
  8. Call R. S., Smith T. F., Morris E., Chapman M. D., Platts-Mills T. A. Risk factors for asthma in inner city children. J Pediatr. 1992 Dec;121(6):862–866. doi: 10.1016/s0022-3476(05)80329-4. [DOI] [PubMed] [Google Scholar]
  9. Camargo C. A., Jr, Weiss S. T., Zhang S., Willett W. C., Speizer F. E. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med. 1999 Nov 22;159(21):2582–2588. doi: 10.1001/archinte.159.21.2582. [DOI] [PubMed] [Google Scholar]
  10. Chomarat P., Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol. 1998;17(1-4):1–52. doi: 10.3109/08830189809084486. [DOI] [PubMed] [Google Scholar]
  11. Chung K. F., Barnes P. J. Cytokines in asthma. Thorax. 1999 Sep;54(9):825–857. doi: 10.1136/thx.54.9.825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Corry D. B., Kheradmand F. Induction and regulation of the IgE response. Nature. 1999 Nov 25;402(6760 Suppl):B18–B23. doi: 10.1038/35037014. [DOI] [PubMed] [Google Scholar]
  13. Devalia J. L., Davies R. J. Airway epithelial cells and mediators of inflammation. Respir Med. 1993 Aug;87(6):405–408. doi: 10.1016/0954-6111(93)90064-7. [DOI] [PubMed] [Google Scholar]
  14. Durham S. R., Ying S., Varney V. A., Jacobson M. R., Sudderick R. M., Mackay I. S., Kay A. B., Hamid Q. A. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol. 1996 Jun;97(6):1356–1365. doi: 10.1016/s0091-6749(96)70205-1. [DOI] [PubMed] [Google Scholar]
  15. Fredberg J. J., Inouye D. S., Mijailovich S. M., Butler J. P. Perturbed equilibrium of myosin binding in airway smooth muscle and its implications in bronchospasm. Am J Respir Crit Care Med. 1999 Mar;159(3):959–967. doi: 10.1164/ajrccm.159.3.9804060. [DOI] [PubMed] [Google Scholar]
  16. Gately M. K., Renzetti L. M., Magram J., Stern A. S., Adorini L., Gubler U., Presky D. H. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol. 1998;16:495–521. doi: 10.1146/annurev.immunol.16.1.495. [DOI] [PubMed] [Google Scholar]
  17. Gavett S. H., O'Hearn D. J., Li X., Huang S. K., Finkelman F. D., Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med. 1995 Nov 1;182(5):1527–1536. doi: 10.1084/jem.182.5.1527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Grünig G., Warnock M., Wakil A. E., Venkayya R., Brombacher F., Rennick D. M., Sheppard D., Mohrs M., Donaldson D. D., Locksley R. M. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998 Dec 18;282(5397):2261–2263. doi: 10.1126/science.282.5397.2261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Haczku A., Takeda K., Redai I., Hamelmann E., Cieslewicz G., Joetham A., Loader J., Lee J. J., Irvin C., Gelfand E. W. Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1638–1643. doi: 10.1164/ajrccm.159.5.9711040. [DOI] [PubMed] [Google Scholar]
  20. Halonen M., Stern D. A., Wright A. L., Taussig L. M., Martinez F. D. Alternaria as a major allergen for asthma in children raised in a desert environment. Am J Respir Crit Care Med. 1997 Apr;155(4):1356–1361. doi: 10.1164/ajrccm.155.4.9105079. [DOI] [PubMed] [Google Scholar]
  21. Hesselmar B., Aberg N., Aberg B., Eriksson B., Björkstén B. Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy. 1999 May;29(5):611–617. doi: 10.1046/j.1365-2222.1999.00534.x. [DOI] [PubMed] [Google Scholar]
  22. Holt P. G., Macaubas C., Stumbles P. A., Sly P. D. The role of allergy in the development of asthma. Nature. 1999 Nov 25;402(6760 Suppl):B12–B17. doi: 10.1038/35037009. [DOI] [PubMed] [Google Scholar]
  23. Holt P. G., Sly P. D. Prevention of adult asthma by early intervention during childhood: potential value of new generation immunomodulatory drugs. Thorax. 2000 Aug;55(8):700–703. doi: 10.1136/thorax.55.8.700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Holt P. G., Stumbles P. A. Regulation of immunologic homeostasis in peripheral tissues by dendritic cells: the respiratory tract as a paradigm. J Allergy Clin Immunol. 2000 Mar;105(3):421–429. doi: 10.1067/mai.2000.105010. [DOI] [PubMed] [Google Scholar]
  25. Humbert M., Durham S. R., Kimmitt P., Powell N., Assoufi B., Pfister R., Menz G., Kay A. B., Corrigan C. J. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol. 1997 May;99(5):657–665. doi: 10.1016/s0091-6749(97)70028-9. [DOI] [PubMed] [Google Scholar]
  26. Ishizaka K., Ishizaka T., Hornbrook M. M. Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. J Immunol. 1966 Jul;97(1):75–85. [PubMed] [Google Scholar]
  27. John M., Lim S., Seybold J., Jose P., Robichaud A., O'Connor B., Barnes P. J., Chung K. F. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med. 1998 Jan;157(1):256–262. doi: 10.1164/ajrccm.157.1.9703079. [DOI] [PubMed] [Google Scholar]
  28. Kim T. S., DeKruyff R. H., Rupper R., Maecker H. T., Levy S., Umetsu D. T. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J Immunol. 1997 May 1;158(9):4137–4144. [PubMed] [Google Scholar]
  29. Kohno K., Kurimoto M. Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both. Clin Immunol Immunopathol. 1998 Jan;86(1):11–15. doi: 10.1006/clin.1997.4475. [DOI] [PubMed] [Google Scholar]
  30. Lack G., Bradley K. L., Hamelmann E., Renz H., Loader J., Leung D. Y., Larsen G., Gelfand E. W. Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J Immunol. 1996 Aug 15;157(4):1432–1439. [PubMed] [Google Scholar]
  31. Leckie M. J., ten Brinke A., Khan J., Diamant Z., O'Connor B. J., Walls C. M., Mathur A. K., Cowley H. C., Chung K. F., Djukanovic R. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2000 Dec 23;356(9248):2144–2148. doi: 10.1016/s0140-6736(00)03496-6. [DOI] [PubMed] [Google Scholar]
  32. Levitt R. C., McLane M. P., MacDonald D., Ferrante V., Weiss C., Zhou T., Holroyd K. J., Nicolaides N. C. IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders. J Allergy Clin Immunol. 1999 May;103(5 Pt 2):S485–S491. doi: 10.1016/s0091-6749(99)70165-x. [DOI] [PubMed] [Google Scholar]
  33. Li L., Xia Y., Nguyen A., Lai Y. H., Feng L., Mosmann T. R., Lo D. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol. 1999 Mar 1;162(5):2477–2487. [PubMed] [Google Scholar]
  34. Lim S., Crawley E., Woo P., Barnes P. J. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet. 1998 Jul 11;352(9122):113–113. doi: 10.1016/S0140-6736(98)85018-6. [DOI] [PubMed] [Google Scholar]
  35. Luder E., Melnik T. A., DiMaio M. Association of being overweight with greater asthma symptoms in inner city black and Hispanic children. J Pediatr. 1998 Apr;132(4):699–703. doi: 10.1016/s0022-3476(98)70363-4. [DOI] [PubMed] [Google Scholar]
  36. Miles E. A., Warner J. A., Jones A. C., Colwell B. M., Bryant T. N., Warner J. O. Peripheral blood mononuclear cell proliferative responses in the first year of life in babies born to allergic parents. Clin Exp Allergy. 1996 Jul;26(7):780–788. [PubMed] [Google Scholar]
  37. Mosmann T. R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 1996 Mar;17(3):138–146. doi: 10.1016/0167-5699(96)80606-2. [DOI] [PubMed] [Google Scholar]
  38. Platts-Mills T. A., Tovey E. R., Mitchell E. B., Moszoro H., Nock P., Wilkins S. R. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet. 1982 Sep 25;2(8300):675–678. doi: 10.1016/s0140-6736(82)90709-7. [DOI] [PubMed] [Google Scholar]
  39. Platts-Mills T. A., Woodfolk J. A., Chapman M. D., Heymann P. W. Changing concepts of allergic disease: the attempt to keep up with real changes in lifestyles. J Allergy Clin Immunol. 1996 Dec;98(6 Pt 3):S297–S306. [PubMed] [Google Scholar]
  40. Platts-Mills T. A., Woodfolk J. A. Cord blood proliferative responses to inhaled allergens: is there a phenomenon? J Allergy Clin Immunol. 2000 Sep;106(3):441–443. doi: 10.1067/mai.2000.109427. [DOI] [PubMed] [Google Scholar]
  41. Platts-Mills T., Vaughan J., Squillace S., Woodfolk J., Sporik R. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet. 2001 Mar 10;357(9258):752–756. doi: 10.1016/S0140-6736(00)04168-4. [DOI] [PubMed] [Google Scholar]
  42. Prescott S. L., Macaubas C., Smallacombe T., Holt B. J., Sly P. D., Loh R., Holt P. G. Reciprocal age-related patterns of allergen-specific T-cell immunity in normal vs. atopic infants. Clin Exp Allergy. 1998 Nov;28 (Suppl 5):39–51. doi: 10.1046/j.1365-2222.1998.028s5039.x. [DOI] [PubMed] [Google Scholar]
  43. Pretolani M., Goldman M. IL-10: a potential therapy for allergic inflammation? Immunol Today. 1997 Jun;18(6):277–280. doi: 10.1016/s0167-5699(97)80023-0. [DOI] [PubMed] [Google Scholar]
  44. Rosenstreich D. L., Eggleston P., Kattan M., Baker D., Slavin R. G., Gergen P., Mitchell H., McNiff-Mortimer K., Lynn H., Ownby D. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med. 1997 May 8;336(19):1356–1363. doi: 10.1056/NEJM199705083361904. [DOI] [PubMed] [Google Scholar]
  45. Rowntree S., Cogswell J. J., Platts-Mills T. A., Mitchell E. B. Development of IgE and IgG antibodies to food and inhalant allergens in children at risk of allergic disease. Arch Dis Child. 1985 Aug;60(8):727–735. doi: 10.1136/adc.60.8.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Saunders M. A., Mitchell J. A., Seldon P. M., Yacoub M. H., Barnes P. J., Giembycz M. A., Belvisi M. G. Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone. Br J Pharmacol. 1997 Feb;120(4):545–546. doi: 10.1038/sj.bjp.0700998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Seaton A., Godden D. J., Brown K. Increase in asthma: a more toxic environment or a more susceptible population? Thorax. 1994 Feb;49(2):171–174. doi: 10.1136/thx.49.2.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Skloot G., Permutt S., Togias A. Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest. 1995 Nov;96(5):2393–2403. doi: 10.1172/JCI118296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Spiteri M. A., Knight R. A., Jeremy J. Y., Barnes P. J., Chung K. F. Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma. Eur Respir J. 1994 Aug;7(8):1431–1438. doi: 10.1183/09031936.94.07081431. [DOI] [PubMed] [Google Scholar]
  50. Sporik R., Ingram J. M., Price W., Sussman J. H., Honsinger R. W., Platts-Mills T. A. Association of asthma with serum IgE and skin test reactivity to allergens among children living at high altitude. Tickling the dragon's breath. Am J Respir Crit Care Med. 1995 May;151(5):1388–1392. doi: 10.1164/ajrccm.151.5.7735590. [DOI] [PubMed] [Google Scholar]
  51. Sporik R., Squillace S. P., Ingram J. M., Rakes G., Honsinger R. W., Platts-Mills T. A. Mite, cat, and cockroach exposure, allergen sensitisation, and asthma in children: a case-control study of three schools. Thorax. 1999 Aug;54(8):675–680. doi: 10.1136/thx.54.8.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Strachan D. P. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax. 2000 Aug;55 (Suppl 1):S2–10. doi: 10.1136/thorax.55.suppl_1.s2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Strachan D. P., Harkins L. S., Johnston I. D., Anderson H. R. Childhood antecedents of allergic sensitization in young British adults. J Allergy Clin Immunol. 1997 Jan;99(1 Pt 1):6–12. doi: 10.1016/s0091-6749(97)70294-x. [DOI] [PubMed] [Google Scholar]
  54. Stumbles P. A., Thomas J. A., Pimm C. L., Lee P. T., Venaille T. J., Proksch S., Holt P. G. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med. 1998 Dec 7;188(11):2019–2031. doi: 10.1084/jem.188.11.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Svanes C., Jarvis D., Chinn S., Burney P. Childhood environment and adult atopy: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):415–420. doi: 10.1016/s0091-6749(99)70465-3. [DOI] [PubMed] [Google Scholar]
  56. Van Neerven R. J., Van de Pol M. M., Van der Zee J. S., Stiekema F. E., De Boer M., Kapsenberg M. L. Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression. Clin Exp Allergy. 1998 Jul;28(7):808–816. doi: 10.1046/j.1365-2222.1998.00306.x. [DOI] [PubMed] [Google Scholar]
  57. Van Oosterhout A. J., Hofstra C. L., Shields R., Chan B., Van Ark I., Jardieu P. M., Nijkamp F. P. Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma. Am J Respir Cell Mol Biol. 1997 Sep;17(3):386–392. doi: 10.1165/ajrcmb.17.3.2679. [DOI] [PubMed] [Google Scholar]
  58. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T. Y., Karp C. L., Donaldson D. D. Interleukin-13: central mediator of allergic asthma. Science. 1998 Dec 18;282(5397):2258–2261. doi: 10.1126/science.282.5397.2258. [DOI] [PubMed] [Google Scholar]
  59. Zuany-Amorim C., Hailé S., Leduc D., Dumarey C., Huerre M., Vargaftig B. B., Pretolani M. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest. 1995 Jun;95(6):2644–2651. doi: 10.1172/JCI117966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. de Vries J. E., Carballido J. M., Aversa G. Receptors and cytokines involved in allergic TH2 cell responses. J Allergy Clin Immunol. 1999 May;103(5 Pt 2):S492–S496. doi: 10.1016/s0091-6749(99)70166-1. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES